Trinity Biotech (TRIB) Operating Expenses (2016 - 2024)
Trinity Biotech's Operating Expenses history spans 16 years, with the latest figure at -$9.8 million for Q4 2024.
- On a quarterly basis, Operating Expenses fell 21.95% to -$9.8 million in Q4 2024 year-over-year; TTM through Dec 2025 was -$17.4 million, a 47.98% increase, with the full-year FY2025 number at $28.3 million, down 16.06% from a year prior.
- Operating Expenses hit -$9.8 million in Q4 2024 for Trinity Biotech, down from -$7.5 million in the prior quarter.
- Over the last five years, Operating Expenses for TRIB hit a ceiling of -$6.2 million in Q2 2020 and a floor of -$10.8 million in Q4 2022.
- Historically, Operating Expenses has averaged -$7.9 million across 5 years, with a median of -$7.5 million in 2020.
- Biggest five-year swings in Operating Expenses: tumbled 66.22% in 2022 and later rose 25.69% in 2023.
- Tracing TRIB's Operating Expenses over 5 years: stood at -$8.2 million in 2020, then rose by 20.03% to -$6.5 million in 2021, then crashed by 66.22% to -$10.8 million in 2022, then grew by 25.69% to -$8.1 million in 2023, then decreased by 21.95% to -$9.8 million in 2024.
- Business Quant data shows Operating Expenses for TRIB at -$9.8 million in Q4 2024, -$7.5 million in Q3 2024, and -$7.4 million in Q2 2024.